Status:
UNKNOWN
Busulfan and Fludarabine as Conditioning for Allogeneic Stem Cell Transplantation: a Pharmacokinetic Study
Lead Sponsor:
Alberta Health services
Conditions:
Hematologic Malignancy
Eligibility:
All Genders
Up to 70 years
Phase:
NA
Brief Summary
A study of pharmacokinetics of daily intravenous busulfan
Detailed Description
A study of pharmacokinetics of daily intravenous busulfan
Eligibility Criteria
Inclusion
- patients undergoing transplantation
Exclusion
- \-
Key Trial Info
Start Date :
January 1 1998
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2010
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT00156858
Start Date
January 1 1998
End Date
December 1 2010
Last Update
January 19 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Tom Baker Cancer Centre
Calgary, Alberta, Canada, T2N 4N2